![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1139, 2007-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quadrivalent HPV vaccine immunogenic, safe
Inpharma, Vol. 1, Iss. 1489, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quadrivalent HPV vaccine may prevent cervical cancer
Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Quadrivalent HPV L1 VLP vaccine prevents vulval, vaginal lesions
Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HPV vaccine safety data reviewed
Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. :